Carbapenem-resistant Enterobacteriaceae (CRE) pose a severe worldwide health crisis. However, there are limited data on the prevalence of CRE in Nigeria. This study investigated the prevalence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates from three primary healthcare facilities in Abuja, Nigeria. Urine specimens ( n = 400) were cultured using conventional microbiological techniques. Isolated E. coli and K. pneumoniae were further characterized by antibiotics susceptibility testing and a PCR assay to screen for bla KPC , bla NDM , and bla IMP genes. Out of the 400 samples, 181 (45.25%) yielded positive cultures: 156 (39%) E. coli and 25 (6.25%) K. pneumoniae. The PCR assay revealed that the bla NDM gene was the most predominant carbapenemase (41.67%), followed by bla KPC and bla IMP (33.33% each). Co-occurrence of all three genes was detected in some isolates, which will significantly compromise therapeutic efficacy. A critical finding was the significantly higher prevalence and co-carriage of these carbapenemase genes in K. pneumoniae compared to E. coli , identifying it as a high-risk reservoir in this setting. This study provides novel insights into the species-specific dynamics of carbapenem resistance in Nigeria, underscoring the urgent need for targeted surveillance and strengthened infection control measures.
No takes yet. Share an insight, caveat, or question.
Obi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: